Cas:315-80-0 dibenzepine hcl manufacturer & supplier

Chemical Name:dibenzepine hcl

CAS.NO:315-80-0

Synonyms:hydrofluoride-1927wander;neodalit;Ansiopax;Dibenzepine;dibenzepinhydrochloride;dibenzepine hydrochloride;noveril;ecatril

Molecular Formula:C₁₈H₂₂ClN₃O

Molecular Weight:331.84000

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:451.7ºC at 760mmHg

Density:N/A

Index of Refraction:

PSA:30.17000

Exact Mass:331.14500

LogP:3.41900

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:UN 3249

Packing Group:III

Contact us for information like hydrofluoride-1927wander chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,ecatril physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Dibenzepine Use and application,dibenzepinhydrochloride technical grade,usp/ep/jp grade.

Related News: A combination of Imbruvica and AbbVie and Roche’s Venclexta slashed the risk of cancer progression or death by 78.4% compared with a cocktail of Roche’s Gazyva and the chemotherapy chlorambucil in previously untreated CLL. The data, from the phase 3 GLOW trial, were shared at the European Hematology Association (EHA) annual meeting. dibenzepine hcl manufacturer Profitability continued to improve. The company’s comprehensive gross profit margin for the first three quarters was 36.06%, a year-on-year increase of 3.44 percentage points. Since this year, the company’s profitability has remained at a relatively high level. On the one hand, due to the decline in the trading business with lower profitability, the proportion has declined. dibenzepine hcl supplier In recent years, China’s bulk drug companies have gradually completed the upgrade of the product structure of bulk raw materials to specialty raw materials and intermediates. The industry’s leading companies have further developed the research and development layout of high-barrier generic pharmaceutical raw materials with multiple patents that have not yet expired. dibenzepine hcl vendor The first is the API �C which is the central ingredient. dibenzepine hcl factory A combination of Imbruvica and AbbVie and Roche’s Venclexta slashed the risk of cancer progression or death by 78.4% compared with a cocktail of Roche’s Gazyva and the chemotherapy chlorambucil in previously untreated CLL. The data, from the phase 3 GLOW trial, were shared at the European Hematology Association (EHA) annual meeting.